Clinical trial
Efficacy and Safety Profile of Cisatracurium Besylate for Intra-abdominal Hypertensiona: Single Center, Randomized, Controlled Trial
NCT05172531 is registered in ClinicalTrials.gov with Tianjin Nankai Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety Profile of Cisatracurium Besylate for Intra-abdominal Hypertensiona: Single Center, Randomized, Controlled Trial
- Lead sponsor
- Tianjin Nankai Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 29, 2022
- Completion date
- April 1, 2023
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.